I have never read that they have ever made 3D cells.Your mate...

I have never read that they have ever made 3D cells.

Your mate Hector typed a lot of rubbish but he was right about the manufacturing manager of circa 2020. He was going on pod casts and similar at the time and really talking down 3D and how difficult and mission critical it was and how unsure he was that it could get done. Soon after those interviews, he was given the arse and since then no one in manufacturing has uttered a peep. Like everyone else in MSB, they have all taken a vow of silence.

So since then there was a CR to pay for some of it and then radio silence, BUT, manufacturing costs, quarter in and quarter out.

So once again, who knows? Not MSB shareholders.



It's bleeding edge technology that the company has shown is not finished. I don't know how everyone has them manufacturing all these cells via 3D is well beyond me - it's a HotCopper fact. That is, it's utter BS but has grown legs because people here want to believe it's true.

Bleeding edge technology costs cash and takes time.

The BoDs tell us they are going to deliver 3D in 2024. The CLBP trial just started. They also tell us they are going to get partnerships in 2024 - that makes sense as someone has to pay for 3D. How does your 2D trial, 3D EAP theory fits in with this timing....? It doesn't really - the doses will be needed by near year's end and if they tell us they will have it in 2024....then? Well....then.....the partnership would want to be done soon, hey?